Albert Sabin: The Jewish Scientist Who Made Polio Vaccination Painless

From Bialystok to Cincinnati

Albert Bruce Sabin was born Abram Saperstein on August 26, 1906, in Bialystok, then part of the Russian Empire (now Poland). His family was part of the large Jewish community in Bialystok, a city that had experienced devastating pogroms. In 1921, the Saperstein family emigrated to the United States, settling in Paterson, New Jersey, where they changed their surname to Sabin.

The young Albert’s path to medicine began with a relative’s gift. A dentist uncle offered to pay for dental school, but Sabin had already been captivated by Paul de Kruif’s book Microbe Hunters, which chronicled the adventures of scientists who discovered the causes of infectious diseases. He told his uncle he would study microbiology instead, and enrolled at New York University.

The Rivalry Begins

When Sabin began his career in virology during the 1930s, polio was one of the most terrifying diseases in America. Each summer brought new epidemics that paralyzed thousands of children. Iron lungs filled hospital wards. Parents kept children away from swimming pools and movie theaters in desperate attempts to avoid the virus.

Jonas Salk, another Jewish scientist, developed the first successful polio vaccine in 1955, using killed virus delivered by injection. It was a triumph — but Sabin believed he had a better approach. He had been working for years on a vaccine using live but weakened poliovirus that could be swallowed rather than injected.

The scientific debate between the two men became intensely personal. Sabin was combative and outspoken, publicly questioning the durability of Salk’s killed-virus vaccine. Salk, for his part, resented Sabin’s dismissive attitude. Their rivalry would persist for decades.

The Sugar Cube Solution

Sabin’s oral vaccine had several advantages over Salk’s injection. The live attenuated virus replicated briefly in the intestines, producing robust immunity not just in the bloodstream but in the gut — the primary site of poliovirus infection. This intestinal immunity could actually prevent transmission of wild poliovirus, something Salk’s injected vaccine could not do as effectively.

The oral vaccine was also dramatically easier to administer. No needles, no trained medical personnel required — just a few drops on a sugar cube. This made it ideal for mass vaccination campaigns in developing countries where trained nurses and sterile syringes were scarce.

Unable to conduct large-scale trials in the United States, where Salk’s vaccine was already in wide use, Sabin turned to the Soviet Union. In a remarkable Cold War collaboration, millions of Soviet children received Sabin’s oral vaccine in the late 1950s. The results were spectacular: safe, effective, and cheap to produce.

Global Impact

The World Health Organization adopted Sabin’s oral polio vaccine (OPV) as its primary tool for global polio eradication. Its ease of administration made it possible to vaccinate children in remote villages across Africa, Asia, and Latin America. Volunteer health workers needed only minutes of training to administer the drops.

By the early twenty-first century, polio cases had declined from hundreds of thousands annually to fewer than a hundred worldwide. The oral polio vaccine was directly responsible for this achievement. Sabin’s decision not to patent the vaccine — forgoing what would have been billions of dollars in royalties — made global distribution economically feasible.

“Could you patent the sun?” Jonas Salk had famously said about his own vaccine. Sabin acted on the same principle, though the two men could agree on little else. Sabin estimated that patenting the vaccine would have earned him $7 billion. He never regretted the decision.

Jewish Values in Scientific Practice

Sabin’s refusal to profit from his vaccine resonated deeply with Jewish ethical traditions. The concept of tikkun olam — repairing the world — holds that individuals bear responsibility for addressing suffering wherever they find it. Sabin embodied this principle through his scientific work and his insistence that the vaccine be freely available.

He remained conscious of his Jewish identity throughout his life. The experience of growing up in pogrom-threatened Bialystok gave him a visceral understanding of vulnerability, and he channeled that awareness into protecting the world’s most vulnerable people — children facing a crippling disease.

Later Career and Honors

Sabin continued active research well into his seventies, investigating possible viral causes of cancer and studying the immune system. He held positions at the University of Cincinnati, the Weizmann Institute of Science in Israel, and the National Institutes of Health.

He received the Presidential Medal of Freedom in 1986 and numerous international honors. The Sabin Vaccine Institute, founded in his honor, continues to advance vaccine research and access worldwide.

Sabin died on March 3, 1993, in Washington, D.C. His oral polio vaccine had by then been administered to over a billion children. The sugar cube that delivered it became one of the most recognizable symbols of public health in history — and a testament to the principle that some discoveries are too important to own.